US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Thursday that its board of directors has declared a dividend of USD2.52 per share for the third quarter of 2026.
This amount is unchanged from the previous quarterly dividend.
Stockholders of record as of the close of business on 21 August 2026 will receive the dividend on 11 September 2026.
CVS Health declares unchanged quarterly dividend
Abbott declares 411th consecutive quarterly dividend
AbbVie declares quarterly dividend of USD1.73 per share
Alvotech and Lotus agree licensing deal for two biosimilar candidates
Quest Diagnostics declares quarterly dividend of of USD0.86 per share
BSF secures exclusive global commercialisation partnership for ETSYL
Saniona grants AstronauTx worldwide rights to neurological disease programme
Ridgetech reports financial results for fiscal year to March 2026
AMGEN announces Q3 2026 dividend
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share